Does the VTS1000 Infra Red Vein Imager Allow Better Identification of Veins Than Normal Eyesight?
VFvalidation
Validation of Vue Tek Digital Vein Viewing Device
1 other identifier
observational
106
1 country
1
Brief Summary
VueTek has developed a head mounted device that will improve the viewing of superficial, subcutaneous vasculature, differentiating it with higher contrast from surrounding tissue. Video of the vasculature is displayed to the user in a portable headset. The headset and display combination facilitates both visualization in the display and an open field of view directly to the subject's anatomy and practitioner's surroundings. The goal is to provide a non-diagnostic, enhanced visual aide that is used alongside standard visual and tactile methodology. The primary and secondary objectives of this validation are as follows:
- 1.Primary Objective:
- 2.Secondary Objective:
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 3, 2010
CompletedFirst Posted
Study publicly available on registry
June 7, 2010
CompletedJune 7, 2010
February 1, 2010
Same day
March 3, 2010
June 4, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To demonstrate that the VTS1000 affords visualization of superficial, subcutaneous vascular structures, when compared to the naked eye.
Ten (10) or more independent qualified practitioners trained to operate the device in accordance with the Directions For Use (DFU), and after completing the Device Usability aspect of the study, will be asked to perform simulated procedures with and without the device as indicated in the DFU on one-hundred (100) or more subjects using the following subject population and sampling table. A minimum of one hundred (100) or more data collection observations will be recorded, tabulated and reported.
Immediate
Secondary Outcomes (1)
To demonstrate that the VTS1000 enhances visualization of superficial, subcutaneous vascular structures over the naked eye.
Immediate
Study Arms (2)
Normal vision
This within-subjects design is counter balanced for order. Each operator sees the subject's arm either initially with the normal eye or with the device, then repeats with the second condition (i.e., device or normal vision).
Vein Imaging Device
This within-subjects design is counter balanced for order. Each operator sees the subject's arm either initially with the normal eye or with the device, then repeats with the second condition (i.e., device or normal vision).
Eligibility Criteria
Ages 4 weeks and above Light skin Dark skin Normal weight Obese weight
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Luke's-Roosevelt Hospital Centerlead
- Vue Tek Scientificcollaborator
Study Sites (1)
St. Luke's Roosevelt Hospitals
New York, New York, 10019, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Franco Resta-Flarer, M.D.
St. Luke's Roosevelt Hospitals
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 3, 2010
First Posted
June 7, 2010
Study Start
February 1, 2010
Primary Completion
February 1, 2010
Study Completion
February 1, 2010
Last Updated
June 7, 2010
Record last verified: 2010-02